Author: ["Hui Miao","Bih-Rong Wei","Donna M. Peehl","Qing Li","Terry Alexandrou","Jeffrey R. Schelling","Johng S. Rhim","John R. Sedor","Elisabeth Burnett","Bingcheng Wang"]
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation1,2. However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation3,4 or to transform rodent fibroblasts5, indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.Cite this article
Miao, H., Wei, BR., Peehl, D. et al. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 3, 527–530 (2001). https://doi.org/10.1038/35074604 